• Tomivosertib: From eIF4E Signal to Assay Design

  2026-09-04

  Tomivosertib is a potent MNK1 inhibitor for resolving how MNK-dependent eIF4E phosphorylation connects tumor-cell survival with glioblastoma angiogenesis. This guide translates the key glioblastoma evidence into practical model-selection, control, and assay-interpretation strategies.

• Naftifine HCl: Designing Better Antifungal Assays

  2026-09-04

  Naftifine HCl is an allylamine antifungal agent whose value extends beyond routine growth inhibition assays. This guide explains how to connect sterol-pathway biology, orthogonal readouts, solvent control, and lessons from multidimensional muscle-cell research to build more interpretable antifungal experiments.

• Moesin as a Biomarker of Endothelial Injury in Sepsis

  2026-09-03

  Chen et al. identified circulating moesin as a marker associated with endothelial injury and sepsis severity, linking serum levels to SOFA scores, procalcitonin, and experimental lung damage. The study also connects moesin to ROCK1/MLC and NF-κB signaling in endothelial cells, providing a mechanistic basis for future biomarker and vascular-barrier research.

• Moxidectin for Antifungal Synergy Research

  2026-09-03

  Moxidectin is an established veterinary antiparasitic now being evaluated as an ergosterol-directed potentiator for polyene antifungal research. This guide translates the finding into practical workflows for Candida growth, biofilm, mechanism, and preclinical validation assays while separating evidence-backed observations from assay-development recommendations.

• From Fluorescent mRNA to Translational Confidence

  2026-09-02

  A thought-leadership guide to using ARCA Cy5 EGFP mRNA (5-moUTP) as a mechanistic bridge between delivery, intracellular localization, and functional translation in mammalian systems, with lessons from targeted mRNA nanoparticles in ischemic stroke.

• Thymosin-β4, Notch/NF-κB, and Limb Ischemia

  2026-09-02

  The reference study shows that thymosin-β4 promotes endothelial activity and angiogenic remodeling in a critical limb ischemia mouse model, with evidence implicating coordinated Notch and NF-κB signaling. Its combination of endothelial-cell assays, pathway inhibitors, and tissue-level measurements provides a useful framework for evaluating pharmacological NF-κB modulation in vascular repair research.

• Iron Stress Reprograms Enterocyte Metabolism

  2026-09-01

  Navazesh and Ji used deferiprone- and ferric ammonium citrate-based perturbations in IPEC-J2 enterocytes to distinguish the metabolic consequences of cellular iron deficiency from iron excess. Their transcriptomic and untargeted metabolomics framework links iron deficiency to impaired proliferation and glycolytic compensation, while showing that iron excess favors cholesterol synthesis and lowers alpha-tocopherol.

• Drug Response Metrics in Cancer In Vitro

  2026-09-01

  Hannah Schwartz’s 2022 dissertation examines why relative viability and fractional viability should not be treated as interchangeable measures of anticancer drug response. Its central contribution is a framework for separating growth inhibition from cell killing, improving interpretation of concentration-response experiments and the timing of drug effects.

• Benzyl-activated Streptavidin Magnetic Beads

  2026-08-31

  Benzyl-activated Streptavidin Magnetic Beads provide a selective route for capturing biotinylated targets while preserving flexible magnetic workflows. This article connects bead-based assay design with new mechanistic insights into CDC42-dependent HBV entry, emphasizing controls, readouts, and interpretation rather than simple product description.

• G007-LK Tankyrase 1/2 Inhibitor Workflow

  2026-08-31

  Build a mechanism-first workflow around G007-LK to connect tankyrase inhibition with β-catenin turnover, YAP regulation, and tumor-cell growth. The guide combines Wnt reporter assays, degradasome and Hippo-pathway readouts, dose design, and practical troubleshooting for colorectal and hepatocellular carcinoma models.

• Spiroplasma Entry Pathways in Drosophila S2 Cells

  2026-08-30

  The reference study established that Spiroplasma eriocheiris can invade Drosophila Schneider 2 cells through clathrin-mediated endocytosis and macropinocytosis, with infection requiring intact actin and microtubule networks. Its pharmacological infection model provides a tractable framework for dissecting invertebrate host–pathogen interactions while also clarifying the interpretive value and limitations of cytoskeletal perturbation assays.

• Light, Brassinosteroids, and Arabidopsis Root Growth

  2026-08-29

  Peng and Zhai show that light and brassinosteroids regulate Arabidopsis seedling primary-root growth through largely independent effects. By combining BR-status mutants with brassinolide and brassinazole treatments under light and darkness, the study separates endogenous BR activity from chemical-inhibitor effects and identifies a likely toxicity-related limitation of brassinazole interpretation.

• Protease Inhibition Beyond the Mature Enzyme

  2026-08-28

  Protease biology is moving from static enzyme inhibition toward state-aware, cell-contextual discovery. This article examines how mechanistic screening, resistance analysis, and the DiscoveryProbe™ Protease Inhibitor Library can help translational researchers connect protease activity modulation with actionable disease biology.

• Phenothiazines Boost Macrophage Antibacterial Defense

  2026-08-28

  The reference study identifies phenothiazines as host-directed antibacterial leads that strengthen macrophage defense through coordinated lysosomal activity, autophagy, and reactive oxygen species accumulation. Its inhibitor and scavenger experiments, together with perphenazine treatment in a Salmonella Typhimurium model, provide a mechanistic framework for studying intracellular infection without assuming direct bacterial killing.

• Caspase-3 Fluorometric Assay Kit in RCC Apoptosis

  2026-08-27

  Learn how the Caspase-3 Fluorometric Assay Kit can distinguish executioner-caspase activation from broader cell-death outcomes in renal cancer research. This article translates autophagy–apoptosis findings into practical assay design, controls, and interpretation strategies.

8064 records 1/538 page Next 12345 下5页 Last page